Matching slides 31,900
Current window 18,301-18,330
Pages 1,064
Rows per page 30
Loop: 27 Cost Of Inactionclear collectionreset all

Loop

18,301-18,330 of 31,900

filter-aware
14
The slide uses a hexagonal layout to present five key product attributes.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
06
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a hub-and-spoke diagram to illustrate data integration and a 2x2 matrix to represent the platform's core capabilities.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a comparative framework to contrast industry standards with AI-enhanced outcomes across two distinct R&D phases.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a process flow diagram to illustrate the transformation of raw data into actionable scientific insights.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
52
The slide uses a flow-chart style to represent patient movement between treatment lines.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
53
Includes qualitative feedback from psychiatrists alongside key findings.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
03
Uses a before-after-bridge style structure to contrast vaccine efficacy with remaining clinical challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide displays two forest plots showing confidence intervals for vaccine effectiveness across multiple studies.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
02
Includes non-GAAP reconciliation footnotes.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
03
Includes non-GAAP adjustments for notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
04
Includes footnotes referenced as (a) and (b).BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
05
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
02
The chart is a dot plot comparing baseline ALSFRS-R scores across various clinical trials, highlighting NurOwn's lower baseline.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
The slide highlights a subgroup analysis where the treatment effect becomes statistically significant (p=0.050) in the secondary endpoint.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Before After1 hit
04
BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slidesBrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
05
The slide uses a timeline-based process diagram to explain the clinical trial structure.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
06
Braskem | ESG Presentation Deck | 54 slidesBraskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
07
The slide uses a dual-row timeline structure to highlight key events in corporate sustainability.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
08
The slide uses a split-layout to contrast internal goal achievement with external validation.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses a central hub-and-spoke style diagram to connect pillars to ambitions, with a footer emphasizing safety as a non-negotiable value.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
10
The slide uses a three-column layout to define strategic pillars.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
17
Includes a market share table for deposits and a logo grid for Fortune 500 companies.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
18
Includes a table of top 15 banks by deposit share in Houston, a comparison table with Dallas, and a logo grid of Fortune 500 companies.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a two-column layout to contrast the New Orleans region with the rest of the state, followed by a competitive table.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
20
Includes a time-series line chart for Texas Lending and bar charts with median benchmarks for other metrics.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a comparison table structure to differentiate between Mucosal PV and Mucocutaneous PV, followed by a list of clinical limitations of current standard-of-care treatments.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
Includes Orphan Drug and Fast Track designation badges.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Includes detailed scientific citations and specific cohort dosing strategies.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Loop · Cost Of Inaction1 hit